Clinical and metabolic factors associated with chronic low-grade inflammation in type 2 diabetic patients

Clinical and metabolic factors associated with chronic low-grade inflammation in type 2 diabetic patients

Aim. To identify the clinical and metabolic factors associated with serum concentration of high sensitivity C-reactive protein (hsCRP) and α1-acid glycoprotein (α1-AGP) in patients with type 2 diabetes.Material and methods. The study involved 210 patients with type 2 diabetes. Levels of hsCRP and α1...

Full description

Bibliographic Details
Main Authors:	Vadim V. Klimontov, Nadezda V. Tyan, Olga N. Fazullina, Natalia E. Myakina, Alexander P. Lykov, Vladimir I. Konenkov
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2016-11-01
Series:	Сахарный диабет
Subjects:	diabetes obesity inflammation glucose variability acute-phase proteins
Online Access:	https://www.dia-endojournals.ru/jour/article/view/7928

Similar Items

The relationships between glucose variability and renal function in type 2 diabetes patients on basal-bolus insulin therapy
by: Vadim V. Klimontov, et al.
Published: (2015-12-01)

Acute-phase serum proteins and adipocytokines in women with type 2 diabetes mellitus: Relationships with body composition and blood glucose fluctuations
by: V V Klimontov, et al.
Published: (2016-10-01)

Ghrelin deficiency in patients with type 2 diabetes: the relationships with obesity, adipose tissue dysfunction and glucose variability
by: V V Klimontov, et al.
Published: (2019-10-01)

Increased serum concentrations of inflammatory cytokines in type 2 diabetic patients with chronic kidney disease
by: V I Konenkov, et al.
Published: (2015-06-01)

Glycaemic variability in diabetes: a tool for assessing the quality of glycaemic control and the risk of complications
by: Vadim Valer'evich Klimontov, et al.
Published: (2014-07-01)

The relationships between bone turnover markers and bone mineral density in postmenopausal type 2 diabetic women
by: Vadim V. Klimontov, et al.
Published: (2016-11-01)

Hypoglycemia in type 2 diabetes patients treated with insulin: the advantages of continuous glucose monitoring
by: Vadim Valer'evich Klimontov, et al.
Published: (2014-03-01)

Bioinformatic Reconstruction and Analysis of Gene Networks Related to Glucose Variability in Diabetes and Its Complications
by: Olga V. Saik, et al.
Published: (2020-11-01)

Glucose Variability: How Does It Work?
by: Vadim V. Klimontov, et al.
Published: (2021-07-01)

Reference values of 24-hour, day-time and nocturnal glucose variability parameters in subjects with normal glucose tolerance
by: Ju. F. Semenova, et al.
Published: (2022-05-01)

The relationship of total body composition with bone mineral density in postmenopausal women with type 2 diabetes
by: Vadim Valer'evich Klimontov, et al.
Published: (2015-03-01)

Defective NOD2 peptidoglycan sensing promotes diet‐induced inflammation, dysbiosis, and insulin resistance
by: Emmanuel Denou, et al.
Published: (2015-03-01)

The Association of Food Insecurity, Inflammation, and Several Socioeconomic Factors with Type 2 Diabetes: A Case-Control Study
by: Hamideh Janzadeh, et al.
Published: (2020-02-01)

Natural deletion of mouse carboxylesterases Ces1c/d/e impacts drug metabolism and metabolic syndrome development
by: Changpei Gan, et al.
Published: (2023-08-01)

Risk factors for decreased bone mineral density in men with type 2 diabetes.
by: Olga N. Fazullina, et al.
Published: (2021-01-01)

VZAIMOSVYaZ' MARKEROV REMODELIROVANIYa KOSTNOY TKANI S KOMPOZITNYM SOSTAVOM TELA I MINERAL'NOY PLOTNOST'Yu KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA V POSTMENOPAUZE
by: O N FAZULLINA, et al.
Published: (2016-08-01)

Stress, Inflammation and Metabolic Biomarkers Are Associated with Body Composition Measures in Lean, Overweight, and Obese Children and Adolescents
by: Eirini V. Christaki, et al.
Published: (2022-02-01)

Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
by: Vadim Valer'evich Klimontov, et al.
Published: (2014-12-01)

Effect of exercise on glucose variability in healthy subjects: randomized crossover trial
by: Franciele Ramos Figueira, et al.
Published: (2019-03-01)

Cystatin C and collagen type IV in diagnostics of chronic kidney disease in type 2 diabetic patients
by: Vadim Valer'evich Klimontov, et al.
Published: (2015-03-01)

Cardamom powder supplementation prevents obesity, improves glucose intolerance, inflammation and oxidative stress in liver of high carbohydrate high fat diet induced obese rats
by: Md Mizanur Rahman, et al.
Published: (2017-08-01)

Effects of balneotherapy on the reactants of acute inflammation phase in Ankylosing spondylitis
by: Stamenković Bojana, et al.
Published: (2009-01-01)

Serum adipokine concentrations in patients with type 2 diabetes: the relationships with distribution, hypertrophy and vascularization of subcutaneous adipose tissue
by: Vadim V. Klimontov, et al.
Published: (2019-10-01)

Impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches
by: Vadim V. Klimontov
Published: (2018-12-01)

Role of Bioactive Compounds in Obesity: Metabolic Mechanism Focused on Inflammation
by: Esther Ramírez-Moreno, et al.
Published: (2022-04-01)

Feeding High-Fat Diet Accelerates Development of Peripheral and Central Insulin Resistance and Inflammation and Worsens AD-like Pathology in APP/PS1 Mice
by: Anna Mengr, et al.
Published: (2023-08-01)

Phase Angle: Could Be an Easy Tool to Detect Low-Grade Systemic Inflammation in Adults Affected by Prader–Willi Syndrome?
by: Luigi Barrea, et al.
Published: (2020-07-01)

The role of inflammation in the metabolic syndrome
by: Ifeoma C Udenze, et al.
Published: (2016-01-01)

Effects of reducing free sugars on 24-hour glucose profiles and glycemic variability in subjects without diabetes
by: Christina Laeticia Pappe, et al.
Published: (2023-10-01)

Gold nanoparticles improve metabolic profile of mice fed a high-fat diet
by: Hui Chen, et al.
Published: (2018-02-01)

SOME PATHOGENETIC ASPECTS OF HYPERTHROPHY AND INFLAMMATION OF PHARYNGEAL TONSILS IN CHILDREN
by: V. N. Zorina, et al.
Published: (2014-07-01)

Inflammation in Metabolic Cardiomyopathy
by: Florian A. Wenzl, et al.
Published: (2021-10-01)

Adipokines and the metabolism of key nutrients in patients with obesity
by: O O Kirillova, et al.
Published: (2014-01-01)

Effect and Regulation of Obesity-Associated Low-Grade Chronic Inflammation in Major Rheumatic Diseases
by: Ana Alonso-Pérez, et al.
Published: (2022-11-01)

Maternal Low-Grade Chronic Inflammation and Intrauterine Programming of Health and Disease
by: Francesca Parisi, et al.
Published: (2021-02-01)

Factors associated with high glucose variability in patients with type 1 diabetes
by: V. V. Klimontov, et al.
Published: (2022-10-01)

Microbiota and Nod-like receptors balance inflammation and metabolism during obesity and diabetes
by: Rodrigo Rodrigues e-Lacerda, et al.
Published: (2023-10-01)

A novel nitroalkene vitamin E analogue inhibits the NLRP3 inflammasome and protects against inflammation and glucose intolerance triggered by obesity
by: Rosina Dapueto, et al.
Published: (2021-02-01)

CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling
by: Vanessa Castelli, et al.
Published: (2021-09-01)

NLRP3 Inflammasome: Potential Role in Obesity Related Low-Grade Inflammation and Insulin Resistance in Skeletal Muscle
by: Gonzalo Jorquera, et al.
Published: (2021-03-01)